Suspension Culture-Mediated Tetraploid Formation in Mouse Embryonic Stem Cells

  • Lee, Jae-Hee (Laboratory of Stem Cell and Bioevaluation, WCU Biomodulation Program, Seoul National University) ;
  • Gong, Seung-Pyo (Department of Marine Biomaterials and Aquaculture, Pukyong National University) ;
  • Lim, Jeong-Mook (Laboratory of Stem Cell and Bioevaluation, WCU Biomodulation Program, Seoul National University) ;
  • Lee, Seung-Tae (Department of Animal Biotechnology, Kangwon National University)
  • Received : 2012.02.22
  • Accepted : 2012.03.26
  • Published : 2012.03.31

Abstract

Suspension culture is a useful tool for culturing embryonic stem (ES) cells in large-scale, but the stability of pluripotency and karyotype has to be maintained $in$ $vitro$ for clinical application. Therefore, we investigated whether the chromosomal abnormality of ES cells was induced in suspension culture or not. The ES cells were cultured in suspension as a form of aggregate with or without mouse embryonic fibroblasts (MEFs), and 0 or 1,000 U/ml leukemia inhibitory factor (LIF) was treated to suspended ES cells. After culturing ES cells in suspension, their karyotype, DNA content, and properties of pluripotency and differentiation were evaluated. As a result, the formation of tetraploid ES cell population was significantly increased in suspension culture in which ES cells were co-cultured with both MEFs and LIF. Tetraploid ES cell population was also generated when ES cells were cultured alone in suspension regardless of the existence of LIF. On the other hand, the formation of tetraploid ES cell population was not detected in LIF-free condition, in which MEFs were included. The origin of tetraploid ES cell population was turned out to be E14 ES cells and not MEFs by microsatellite analysis and the basic properties of them were still maintained despite ploidy-conversion to tetraploidy. Furthermore, we identified the ploidy shift from tetraploidy to near-triploidy as tetraploid ES cells were differentiated spontaneously. From these results, we demonstrated that suspension culture system could induce ploidy-conversion generating tetraploid ES cell population. Moreover, optimization of suspension culture system may make possible mass-production of ES cells.

Keywords

References

  1. Blum B, Benvenisty N (2009): The tumorigenicity of diploid and aneuploid human pluripotent stem cells. Cell Cycle 8:3822-3830. https://doi.org/10.4161/cc.8.23.10067
  2. Chambers I (2004): The molecular basis of pluripotency in mouse embryonic stem cells. Cloning Stem Cells 6:386-391. https://doi.org/10.1089/clo.2004.6.386
  3. Cormier JT, zur Nieden NI, Rancourt DE, Kallos MS (2006): Expansion of undifferentiated murine embryonic stem cells as aggregates in suspension culture bioreactors. Tissue Eng 12:3233-3245. https://doi.org/10.1089/ten.2006.12.3233
  4. Cowan CA, Klimanskaya I, McMahon J, Atienza J, Witmyer J, Zucker JP, Wang S, Morton CC, Mc- Mahon AP, Powers D, Melton DA (2004): Derivation of embryonic stem-cell lines from human blastocysts. N Engl J Med 350:1353-1356. https://doi.org/10.1056/NEJMsr040330
  5. Draper JS, Smith K, Gokhale P, Moore HD, Maltby E, Johnson J, Meisner L, Zwaka TP, Thomson JA, Andrews PW (2004): Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells. Nat Biotechnol 22:53-54. https://doi.org/10.1038/nbt922
  6. Inzunza J, Sahlen S, Holmberg K, Stromberg AM, Teerijoki H, Blennow E, Hovatta O, Malmgren H (2004): Comparative genomic hybridization and karyotyping of human embryonic stem cells reveals the occurrence of an isodicentric X chromosome after long-term cultivation. Mol Hum Reprod 10:461-466. https://doi.org/10.1093/molehr/gah051
  7. Krawetz R, Taiani JT, Liu S, Meng G, Li X, Kallos MS, Rancourt DE (2010): Large-scale expansion of pluripotent human embryonic stem cells in stirred- suspension bioreactors. Tissue Eng Part C Methods 16:573-582. https://doi.org/10.1089/ten.tec.2009.0228
  8. Lee JH, Lee EJ, Lee CH, Park JH, Han JY, Lim JM (2009): Requirement of leukemia inhibitory factor for establishing and maintaining embryonic stem cells in mice. Fertil Steril 92:1133-1140. https://doi.org/10.1016/j.fertnstert.2008.07.1733
  9. Lui KO, Waldmann H, Fairchild PJ (2009): Embryonic stem cells: overcoming the immunological barriers to cell replacement therapy. Curr Stem Cell Res Ther 4:70-80. https://doi.org/10.2174/157488809787169093
  10. Maitra A, Arking DE, Shivapurkar N, Ikeda M, Stastny V, Kassauei K, Sui G, Cutler DJ, Liu Y, Brimble SN, Noaksson K, Hyllner J, Schulz TC, Zeng X, Freed WJ, Crook J, Abraham S, Colman A, Sartipy P, Matsui S, Carpenter M, Gazdar AF, Rao M, Chakravarti A (2005): Genomic alterations in cultured human embryonic stem cells. Nat Genet 37:1099-1103. https://doi.org/10.1038/ng1631
  11. Mitalipova MM, Rao RR, Hoyer DM, Johnson JA, Meisner LF, Jones KL, Dalton S, Stice SL (2005): Preserving the genetic integrity of human embryonic stem cells. Nat Biotechnol 23:19-20. https://doi.org/10.1038/nbt0105-19
  12. Musacchio A, Salmon ED (2007): The spindle-assembly checkpoint in space and time. Nat Rev Mol Cell Biol 8:379-393.
  13. Rello-Varona S, Vitale I, Kepp O, Senovilla L, Jemaa M, Metivier D, Castedo M, Kroemer G (2009): Preferential killing of tetraploid tumor cells by targeting the mitotic kinesin Eg5. Cell Cycle 8:1030- 1035. https://doi.org/10.4161/cc.8.7.7950
  14. Rosler ES, Fisk GJ, Ares X, Irving J, Miura T, Rao MS, Carpenter MK (2004): Long-term culture of human embryonic stem cells in feeder-free conditions. Dev Dyn 229:259-274. https://doi.org/10.1002/dvdy.10430
  15. Shi Q, King RW (2005): Chromosome nondisjunction yields tetraploid rather than aneuploid cells in human cell lines. Nature 437:1038-1042. https://doi.org/10.1038/nature03958
  16. Storchova Z, Pellman D (2004): From polyploidy to aneuploidy, genome instability and cancer. Nat Rev Mol Cell Biol 5:45-54.
  17. zur Nieden NI, Cormier JT, Rancourt DE, Kallos MS (2007): Embryonic stem cells remain highly pluripotent following long term expansion as aggregates in suspension bioreactors. J Biotechnol 129:421-432. https://doi.org/10.1016/j.jbiotec.2007.01.006